Literature DB >> 2974531

Oligoclonal T cell proliferative disorder in combined immunodeficiency.

J Frenkel1, H J Neijens, J C den Hollander, I L Wolvers-Tettero, J J van Dongen.   

Abstract

Oligoclonal lymphoid proliferations may occur in immunocompromised patients and in the elderly. So far these proliferations have been shown to be of B cell origin. We describe a patient with a combined immunodeficiency, characterized by profound hypogammaglobulinemia and the initial absence of T lymphocytes in the peripheral blood (PB). From the age of 4 yr CD3+ T cells appeared in PB in rising numbers. These cells mainly expressed the CD4-/CD8+ phenotype (CD4/CD8 ratio: 0.1). Despite the emergence of T lymphocytes no proliferation of PB mononuclear cells could be induced with phytohemagglutinin, concanavalin A, or pokeweed mitogen. Between the ages of 4 and 6 yr the patient gradually developed hepatosplenomegaly and an interstitial pulmonary infiltrate of unknown origin, necessitating biopsies of both liver and lung. Infiltrates consisting of CD8+ T lymphocytes were found in the liver as well as the lung. CD8+ T cells were also abundant in the bronchoalveolar lavage fluid. Southern blot analysis of mononuclear cells from PB and of a lung biopsy specimen was performed to investigate if a clonal T cell population was involved. Analysis of the T cell receptor beta genes revealed that at least three expanded T cell clones were present in PB, one of which had invaded the lung. Thus far, i.e. 2 yr after the initial detection of clonal T cell receptor beta gene rearrangements, there have been no clinical or histologic signs of malignant behavior. We conclude that this combined immunodeficiency patient has a benign oligoclonal T cell lymphoproliferative disorder. Similar proliferations might well occur in other immunodeficiency states, whether primary or acquired.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974531     DOI: 10.1203/00006450-198811000-00017

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  2 in total

1.  T cell heterogeneity in patients with common variable immunodeficiency as assessed by abnormalities of T cell subpopulations and T cell receptor gene analysis.

Authors:  F Pandolfi; L Trentin; J E San Martin; J T Wong; J T Kurnick; R A Moscicki
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

2.  EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System.

Authors:  Jacques J M van Dongen; Mirjam van der Burg; Tomas Kalina; Martin Perez-Andres; Ester Mejstrikova; Marcela Vlkova; Eduardo Lopez-Granados; Marjolein Wentink; Anne-Kathrin Kienzler; Jan Philippé; Ana E Sousa; Menno C van Zelm; Elena Blanco; Alberto Orfao
Journal:  Front Immunol       Date:  2019-06-13       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.